Lamotrigine and Gabapentin
- 1 October 1998
- journal article
- review article
- Published by S. Karger AG in Neuropsychobiology
- Vol. 38 (3) , 192-197
- https://doi.org/10.1159/000026536
Abstract
The anticonvulsants carbamazepine and sodium valproate have efficacy in hypomania, bipolar depression and in the prophylaxis of bipolar disorder. This paper reviews published evidence on the effects of the new anticonvulsants gabapentin and lamotrigine in bipolar disorder. The conclusion is that there is good evidence from open studies to indicate that randomised double-blind trials of these compounds should be carried out. The pharmacology of these anticonvulsants is reviewed and putative predictors of good response identified.Keywords
This publication has 8 references indexed in Scilit:
- The Anticonvulsant Lamotrigine in Treatment-Resistant Manic-Depressive IllnessJournal of Clinical Psychopharmacology, 1997
- Gabapentin for Treatment of Bipolar and Schizoaffective DisordersJournal of Clinical Psychopharmacology, 1997
- A Case Report of Risperidone-Induced Obsessive-Compulsive SymptomsJournal of Clinical Psychopharmacology, 1997
- New Antiepileptic DrugsNew England Journal of Medicine, 1996
- Neuroprotective effects of lamotrigine in global ischemia in gerbils. A histological, in vivo microdialysis and behavioral studyBrain Research, 1995
- Systemic administration of lithium chloride and tacrine but not kainic acid augments citrulline content of rat brainEuropean Journal of Pharmacology, 1995
- 3-Alkyl GABA and 3-alkylglutamic acid analogues: two new classes of anticonvulsant agentsEpilepsy Research, 1992
- Gabapentin increases aminooxyacetic acid-induced GABA accumulation in several regions of rat brainNeuroscience Letters, 1991